| Eltrombopag and high-dose dexamethasone as frontline treatment of newly diagnosed immune thrombocytopenia in adults D Gómez-Almaguer, MA Herrera-Rojas, JC Jaime-Pérez, ... Blood, The Journal of the American Society of Hematology 123 (25), 3906-3908, 2014 | 102 | 2014 |
| Acute leukemia characteristics are different around the world: the Mexican perspective D Gómez-Almaguer, ER Marcos-Ramírez, EH Montaño-Figueroa, ... Clinical Lymphoma Myeloma and Leukemia 17 (1), 46-51, 2017 | 64 | 2017 |
| Safety and tolerability of intrathecal delivery of autologous bone marrow nucleated cells in children with cerebral palsy: an open-label phase I trial C Mancías-Guerra, AR Marroquín-Escamilla, O González-Llano, ... Cytotherapy 16 (6), 810-820, 2014 | 63 | 2014 |
| Current approaches for the treatment of autoimmune hemolytic anemia JC Jaime-Pérez, M Rodríguez-Martínez, A Gómez-de-León, ... Archivum immunologiae et therapiae experimentalis 61 (5), 385-395, 2013 | 48 | 2013 |
| Comparative analysis of iron status and other hematological parameters in preeclampsia CH Gutierrez-Aguirre, JA García-Lozano, OR Treviño-Montemayor, ... Hematology 22 (1), 36-40, 2017 | 34 | 2017 |
| Allogeneic peripheral blood stem cell transplantation using reduced‐intensity conditioning in an outpatient setting in ABO‐incompatible patients: are survival and graft‐versus … CH Gutiérrez‐Aguirre, A Gómez‐De‐León, J Alatorre‐Ricardo, ... Transfusion 54 (5), 1269-1277, 2014 | 32 | 2014 |
| The 1,000 th transplant for multiple sclerosis and other autoimmune disorders at the HSCT-México program: a myriad of experiences and knowledge I Murrieta-Álvarez, Y Cantero-Fortiz, AA León-Peña, JC Olivares-Gazca, ... Frontiers in Neurology 12, 647425, 2021 | 31 | 2021 |
| Impact of the affordability of novel agents in patients with multiple myeloma: real‐world data of current clinical practice in Mexico L Tarín‐Arzaga, D Arredondo‐Campos, V Martínez‐Pacheco, ... Cancer 124 (9), 1946-1953, 2018 | 29 | 2018 |
| More about low-dose rituximab and plasma exchange as front-line therapy for patients with thrombotic thrombocytopenic purpura A Vazquez-Mellado, M Pequeño-Luévano, OG Cantu-Rodriguez, ... Hematology 21 (5), 311-316, 2016 | 28 | 2016 |
| Effective collection of peripheral blood stem cells in children weighing 20 kilogram or less in a single large‐volume apheresis procedure R Salazar‐Riojas, JA García‐Lozano, M Valdés‐Galván, ... Journal of Clinical Apheresis 30 (5), 281-287, 2015 | 28 | 2015 |
| Eltrombopag, low‐dose rituximab, and dexamethasone combination as frontline treatment of newly diagnosed immune thrombocytopaenia D Gómez Almaguer, PR Colunga Pedraza, A Gómez de León, ... British journal of haematology 184 (2), 288-290, 2019 | 27 | 2019 |
| Low-dose rituximab for the treatment of acute thrombotic thrombocytopenic purpura: report of four cases M Pequeño-Luévano, L Villarreal-Martínez, JC Jaime-Pérez, ... Hematology 18 (4), 233-236, 2013 | 21 | 2013 |
| Treating acute leukemia during the COVID-19 pandemic in an environment with limited resources: a multicenter experience in four Latin American countries R Demichelis-Gómez, M Alvarado-Ibarra, J Vasquez-Chávez, ... JCO global oncology 7, 577-584, 2021 | 19 | 2021 |
| Danazol as first-line therapy for myelodysplastic syndrome PR Colunga-Pedraza, JE Colunga-Pedraza, MA Garza-Ledezma, ... Clinical Lymphoma Myeloma and Leukemia 18 (2), e109-e113, 2018 | 19 | 2018 |
| Treatment of classical Hodgkin’s lymphoma in children and adolescents D Gómez-Almaguer, O González-Llano, V Jiménez-Antolinez, ... Expert Opinion on Pharmacotherapy 20 (10), 1227-1234, 2019 | 16 | 2019 |
| Outpatient allogeneic hematopoietic stem-cell transplantation: a review D Gómez-Almaguer, A Gómez-De León, PR Colunga-Pedraza, ... Therapeutic Advances in Hematology 13, 20406207221080739, 2022 | 15 | 2022 |
| Treatment of autoimmune hemolytic anemia: real world data from a reference center in Mexico JC Jaime-Pérez, P Aguilar-Calderón, L Salazar-Cavazos, ... Blood research 54 (2), 131, 2019 | 15 | 2019 |
| Outpatient haploidentical stem cell transplantation using post-transplant cyclophosphamide is safe and feasible PR Colunga-Pedraza, A Gómez-De León, CS Rodríguez-Roque, ... Transplantation and Cellular Therapy 27 (3), 259. e1-259. e6, 2021 | 14 | 2021 |
| Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012 C Correa, O Gonzalez-Ramella, H Baldomero, AL Basquiera, R Baena, ... Bone Marrow Transplantation 57 (6), 881-888, 2022 | 13 | 2022 |
| Insights on chronic immune thrombocytopenia pathogenesis: a bench to bedside update JC Jaime-Pérez, EM Ramos-Dávila, JD Meléndez-Flores, ... Blood Reviews 49, 100827, 2021 | 13 | 2021 |
